Matthew Goff Investment Advisor, LLC Pfizer Inc Transaction History

Matthew Goff Investment Advisor, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $2.14 Million - $2.59 Million	62,003 New	62,003 $1.71 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $239,072 - $254,874	-7,249 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $21,188 - $24,581	-664 Reduced 8.39%	7,249 $257,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $2,195 - $2,329	66 Added 0.84%	7,913 $287,000
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $28,334 - $31,213	-914 Reduced 10.43%	7,847 $280,000
Q2 2017 Aug 10, 2017	BUY	N/A	8,761	8,761 $294,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Matthew Goff Investment Advisor, LLC, based on Form 13F filings with the SEC.

Stay updated on Matthew Goff Investment Advisor, LLC with notifications on news.